Indication

Infantile malignant osteopetrosis

Infantile malignant osteopetrosis is a rare, severe, autosomal recessive skeletal disorder characterized by defective osteoclast-mediated bone resorption, leading to excessive, dense, and structurally brittle bone formation. Read more about Infantile malignant osteopetrosis

3 drugs 3 manufacturers

Advertisement

Drugs that treat it

Common Infantile malignant osteopetrosis therapies.

Showing 1–3 of 3 drugs

Filter & compare in the drug finder →Opens the drug finder with Infantile malignant osteopetrosis preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Infantile malignant osteopetrosis.

Infantile malignant osteopetrosis is a rare, severe, autosomal recessive skeletal disorder characterized by defective osteoclast-mediated bone resorption, leading to excessive, dense, and structurally brittle bone formation.

Manifesting in the neonatal period or early infancy, this condition severely impacts both the skeletal and hematopoietic systems.

Failure of the marrow cavities to develop results in progressive bone marrow failure presenting with pancytopenia, severe anemia, recurrent infections, and compensatory hepatosplenomegaly.

Additionally, hyperostosis and progressive narrowing of the cranial foramina compress traversing cranial nerves, frequently causing optic atrophy, blindness, sensorineural hearing loss, and facial nerve palsy.

Without intervention, the disease follows a rapidly progressive, life-threatening course.

Personalize your experience

Follow Infantile malignant osteopetrosis and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it